Tolerance Bio, Inc. raised $17.2 million in seed financing led by Columbus Venture Partners to advance thymus-based therapies for immune-mediated diseases.
Amount Raised
$17.2 Million
Round Type
Seed
PhiladelphiaBiotechnologyHealth CareTherapeuticsInvestors
Description
Tolerance Bio, Inc. announced the closing of its oversubscribed $17.2 million seed financing round. The funds will support the development of thymus-based cell therapy platforms and pharmacological therapies for immune-mediated diseases.
Quick answer
Tolerance Bio raised $17.2 Million in a Seed round, dated October 15, 2024. Investors: Criteria Bio Ventures, Sessa Capital, Bio Advance, Ben Franklin Technology Partners and Columbus Venture Partners. Tolerance Bio is based in Philadelphia, Pennsylvania, United States.
- How much did Tolerance Bio raise?
- Tolerance Bio raised $17.2 Million in a Seed round on October 15, 2024.
- Who invested in Tolerance Bio?
- Criteria Bio Ventures, Sessa Capital, Bio Advance, Ben Franklin Technology Partners and Columbus Venture Partners are named as investors in this round.
- What does Tolerance Bio do?
- Tolerance Bio, Inc., is a biopharmaceutical company focused on manipulating immune tolerance via the thymus to address various immune-mediated diseases.
- Where is Tolerance Bio based and how big is it?
- Tolerance Bio is based in Philadelphia, Pennsylvania, United States.
- Who are the decision-makers at Tolerance Bio?
- Fundz holds 1 contact at Tolerance Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Tolerance Bio that raised within 45 days of this round, from Fundz verified event records.
- Celosia Therapeutics raised $17M (Series A) on November 28, 2024.
- Intensity Therapeutics raised $3.6M (Seed) on November 21, 2024.
- Biofrontera raised $4.2M (Seed) on November 21, 2024.
- Debiopharm raised $5.8M (Funding Round) on November 21, 2024.
- HCW Biologics raised $6.9M on November 20, 2024.
- Adipo Therapeutics raised $4.7M (Seed) on November 19, 2024.
Who to call at Tolerance Bio, and when
A new round usually means Tolerance Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tolerance Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tolerance Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tolerance Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tolerance Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Tolerance Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.